Paasa Logo
Cytosorbents Corporation logo
CTSONASDAQMarket closedOpens 9:30am ET

Cytosorbents Corporation

$4.38Last updated
+$0.08 (1.86%)Past day
Timezone

Cytosorbents Corporation (NASDAQ: CTSO) is trading at $4.38, about ₹420 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 1.86% today. Indian residents can buy Cytosorbents from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$4.83
Previous close:$4.30
Volume:6.47K

Today's low

$4.33

Today's high

$4.83

52 week low

$3.94

52 week high

$20.40

CTSO opened at $4.83, closed previously at $4.30, and has traded between $3.94 and $20.40 over the past 52 weeks.

About

Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology. The company's leading product, CytoSorb, is an extracorporeal filter designed to remove cytokines from the blood. It serves as a complementary treatment in various critical care scenarios, including sepsis, managing complications during and after heart bypass surgery, and improving the viability of donor organs for transplantation. Beyond CytoSorb, Cytosorbents offers a portfolio of specialized devices. These include VetResQ, used to assist in treating critical conditions like sepsis and pancreatitis in animals; CytoSorb-XL, another device targeting sepsis and other severe illnesses; HemoDefend, a platform for purifying blood supplies by removing contaminants that cause transfusion reactions and diseases, as well as anti-A and anti-B antibodies from blood products; K+ontrol, designed for patients with severe, life-threatening hyperkalemia; and ContrastSorb, which extracts intravenous contrast agents following imaging procedures (like CT scans, angiograms, or interventional radiology) to mitigate the risk of contrast-induced kidney damage. The company is also actively developing several new solutions: BetaSorb, aimed at preventing and treating complications from metabolic toxin buildup in chronic kidney disease patients; DrugSorb, which focuses on eliminating harmful chemicals from the bloodstream; and DrugSorb-ATR, an innovative system for removing antithrombotic agents. Originally established as MedaSorb Technologies Corporation in 1997, the company adopted its current name, Cytosorbents Corporation, in May 2010. Its corporate headquarters are situated in Princeton, New Jersey.

Country
US
CEO
Phillip Chan
Exchange listed on
NASDAQ
Industry
Medical - Devices
Base currency
USD
Full Time Employees
129
Sector
Healthcare
IPO date
08/08/2006

Key statistics

Avg. volume

11.95K

Market cap

$13.76M

P/E Ratio

-0.76

Price-to-sales ratio

0.37

Enterprise value

$35.68M

Free cash flow yield

-75.75%

Debt-to-equity ratio

-35.07

Return on equity

-445.14%

ROIC

-42.38%

Beta

1.34

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$37.06M

Earnings per share

-$2.60

Free cash flow

-$12.54M

Net profit margin

-48.94%

Gross margin

71.61%

EBITDA

-$4.36M

Revenue growth

4.12%

Similar securities

This is not an investment recommendation

How to buy Cytosorbents from India

Indian residents can buy Cytosorbents shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Cytosorbents and place an order

    Find Cytosorbents by name or by its ticker, CTSO, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Cytosorbents trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Cytosorbents position in USD and INR. Cytosorbents pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Cytosorbents from India

Trading and taxes when buying Cytosorbents from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneCytosorbents does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Cytosorbents stock?

Yes. Cytosorbents (CTSO) has been listed on NASDAQ since 2006, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Cytosorbents share cost in rupees?

One Cytosorbents share is $4.38 — about ₹420 at a USD/INR rate of 95.88 on 26 Sep 2026. Both the Cytosorbents price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Cytosorbents from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Cytosorbents?

Yes. One Cytosorbents share is $4.38, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Cytosorbents.

How are gains on Cytosorbents shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Cytosorbents price. Paasa issues a capital-gains statement for your return.

Does Cytosorbents pay a dividend?

No. Cytosorbents does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Cytosorbents from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Cytosorbents shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Cytosorbents shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Cytosorbents holding, its cost and its closing value.

How do I sell Cytosorbents and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.